ÂÜÀòÂÒÂ×

Amber Cantin is a dedicated scientist with extensive experience in biochemistry and molecular biology. Currently serving as Scientist II at Chroma Medicine since March 2023, Amber previously held various positions at TCR² Therapeutics Inc. from July 2018 to March 2023, including Scientist, Associate Scientist, and Senior Research Associate. Amber's earlier experience includes a Scientist role at Novartis Institutes for BioMedical Research from October 2012 to July 2018. Academic experience includes a Master of Science in Biochemistry and Molecular Biology from the University of Massachusetts Amherst, where Amber also earned a Bachelor of Science in the same fields, along with Microbiology. Research expertise encompasses CHO cell cultures, protein expression, stable cell line generation, and regulatory proteolysis studies.